Cui et al. also found that CTSL expression was higher in NSCLC cells and overexpression of CTSL was positively correlated with gefitinib resistance in non-small cell lung cancer (NSCLC) (Cui et al., 2016). Here, CTSL is linked to non-small cell lung carcinoma.